Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Synthesis 2004(17): 2855-2862
DOI: 10.1055/s-2004-834870
DOI: 10.1055/s-2004-834870
PAPER
© Georg Thieme Verlag Stuttgart · New York
A Convenient Synthesis of New Purinyl-homo-carbonucleosides on a Cyclopentane Ring Fused with Pyridazine
Further Information
Received
30 July 2004
Publication Date:
15 October 2004 (online)
Publication History
Publication Date:
15 October 2004 (online)

Abstract
The new purinyl homo-carbonucleosides 10 and 17a were prepared from 1,4-diphenyl-5,8-dihydro-5,8-methanophthalazine by one-pot ozonolysis and reductive cleavage, followed by monoprotection with an Ac or TBDMS group, mesylation of the resulting diol and replacement of the mesyl group with 6-chloropurine in the presence of NaH and 18-crown-6 ether. Homo-carbonucleosides 12 and 13 were then obtained from 10 by substitution of the chlorine in purine position 6. Compounds 17b and 19 were obtained from 17a in the same way.
Key words
ozonolysis - acylation - diols - carbocyclic nucleosides - heterocycles - pyridazine
-
1a
Cheson BD. Hematol. Cell. Ther. (Suppl. 2) 1996, 38: 109 -
1b
Bergmann L. Leukemia: (Suppl. 2) 1997, 11: 29 -
2a
Borthwick AD.Biggadike K. Tetrahedron 1992, 48: 571 -
2b
Agrofoglio L.Suhas E.Farese A.Condom R.Challand SR.Earl RA.Guedj R. Tetrahedron 1994, 50: 10611 -
2c
Huryn D.Okabe M. Chem. Rev. 1992, 92: 1745 -
2d
Mansour TS.Storer R. Curr. Pharm. Des. 1997, 3: 227 -
2e
Ichikewa E.Kato K. Curr. Med. Chem. 2001, 8: 385 - 3
Crimmins MT.King BW. J. Org. Chem. 1996, 61: 4192 -
4a
Daluge SM.Good SS.Faletto MB.Miller WH.Wayne H.St. Clair MH.Boone LR.Tisdale M.Parry NR.Reardon JE.Dornsife RE.Averett DR.Krenitsky TA. Antimicrob. Agents Chemother. 1997, 41: 1082 -
4b
Faletto MB.Miller WH.St. Clair EP.Garvey MH.Daluge SM.Good SS. Antimicrob. Agents Chemother. 1997, 41: 1099 -
4c
Foster RH.Faulds D. Drugs 1998, 729 -
5a
Fernández F.García-Mera X.Morales M.Rodríguez-Borges JE.De Clercq E. Synthesis 2002, 1084 -
5b
Fernández F.García-Mera X.Morales M.Vilariño L.Caamaño O. Tetrahedron 2004, 60: 9245 - 6
Yao S.-W.Lopes VHC.Fernández F.García-Mera X.Morales M.Rodríguez-Borges JE.Cordeiro MNDS. Bioorg. Med. Chem. 2003, 11: 4999 - 7
Hocek M.Hol A.Votruba I.Dvoráková H. J. Med. Chem. 2000, 43: 1817 -
8a
López C.Caamaño O.Hergueta AR.Fernández F.García MD. Tetrahedron Lett. 2002, 43: 5311 -
8b
García MD.Caamaño O.Fernández F.Figueira MJ.Gómez G. Synthesis 2003, 2138 - 9
Kobayashi T.Sugawara H.Nikaeen B. Bull. Chem. Soc. Jpn. 1998, 71: 497 - 10
Dumas M.Vo-Quang Y.Vo-Quang L.Le Goffic F. Synthesis 1989, 64 -
11a
Mitsunobu O.Yamada M. Bull. Chem. Soc. Jpn. 1967, 40: 2380 -
11b
Mitsunobu O. Synthesis 1981, 1 -
11c
Mitsunobu O.Wata M.Sano T. J. Am. Chem. Soc. 1972, 94: 679 -
11d
Hughes DL. In Organic Reactions Vol. 42:Paquette LA. John Wiley and Sons; New York: 1992. p.344 - 12
Franzyk H.Rasmussen JH.Mazzei RA.Jensen SR. Eur. J. Org. Chem. 1998, 2931 - 13
De Clercq E. In Vivo and Ex Vivo Text Systems to Rationalize Drug Design and DeliveryCromelin D.Couvreur P.Duchene D. Editions de Santé; Paris: 1994.